While the UK continues to develop the future medtech regulatory system for Great Britain, a new market access report recommends how the MHRA should simplify regulatory processes for SMEs.
The possible recognition of devices approved in trusted global markets is a major item on the medtech agenda of the UK as it develops its standalone system.
The Medicines and Healthcare products Regulatory Agency (MHRA) is an official observer of the Medical Device Single Audit Program (MDSAP)....
A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.
Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.
Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it.
